These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7868416)

  • 21. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.
    Dautzenberg B; Saint Marc T; Meyohas MC; Eliaszewitch M; Haniez F; Rogues AM; De Wit S; Cotte L; Chauvin JP; Grosset J
    Arch Intern Med; 1993 Feb; 153(3):368-72. PubMed ID: 8427539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
    Clark JA; Margolis DM
    Clin Infect Dis; 1993 Apr; 16(4):555-7. PubMed ID: 8513064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clarithromycin and MAC.
    AIDS Patient Care STDS; 1996 Feb; 10(1):54. PubMed ID: 11361673
    [No Abstract]   [Full Text] [Related]  

  • 25. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
    Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients.
    Ruf B; Schürmann D; Mauch H; Jautzke G; Fehrenbach FJ; Pohle HD
    Infection; 1992; 20(5):267-72. PubMed ID: 1428183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NIAID study rules out high-dose clarithromycin for AIDS-related MAC.
    AIDS Patient Care STDS; 1996 Oct; 10(5):313. PubMed ID: 11361534
    [No Abstract]   [Full Text] [Related]  

  • 28. New data suggest antibiotic clarithromycin is effective in prolonging life of AIDS patients.
    AIDS Patient Care STDS; 1996 Dec; 10(6):382-3. PubMed ID: 11361575
    [No Abstract]   [Full Text] [Related]  

  • 29. Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection.
    Murray R; Mallal S; Heath C; French M
    Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):199-201. PubMed ID: 11347672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic gets FDA nod for MAC treatment.
    Am J Nurs; 1994 Feb; 94(2):13. PubMed ID: 8304386
    [No Abstract]   [Full Text] [Related]  

  • 31. Different clarithromycin doses affect mortality.
    AIDS Patient Care STDS; 1997 Apr; 11(2):102-3. PubMed ID: 11361754
    [No Abstract]   [Full Text] [Related]  

  • 32. [Management of atypical Mycobacterium infections in AIDS-patients].
    Internist (Berl); 1996 Apr; 37(4 Suppl):1-8. PubMed ID: 9131082
    [No Abstract]   [Full Text] [Related]  

  • 33. Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance.
    Shafran SD
    Clin Infect Dis; 1998 Oct; 27(4):813-5. PubMed ID: 9798038
    [No Abstract]   [Full Text] [Related]  

  • 34. AIDS patients have a new weapon against MAC infection.
    RN; 1994 Mar; 57(3):72. PubMed ID: 8128150
    [No Abstract]   [Full Text] [Related]  

  • 35. Mycobacterium avium intracellulare infection in patients with HIV or AIDS.
    Brettle RP
    J Antimicrob Chemother; 1997 Aug; 40(2):156-60. PubMed ID: 9301979
    [No Abstract]   [Full Text] [Related]  

  • 36. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.
    Chaisson RE; Benson CA; Dube MP; Heifets LB; Korvick JA; Elkin S; Smith T; Craft JC; Sattler FR
    Ann Intern Med; 1994 Dec; 121(12):905-11. PubMed ID: 7978715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An unreported side effect of topical clarithromycin when used successfully to treat Mycobacterium avium-intracellulare keratitis.
    Tyagi AK; Kayarkar VV; McDonnell PJ
    Cornea; 1999 Sep; 18(5):606-7. PubMed ID: 10487437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nontuberculous mycobacterium disease with pleural empyema in a patient with advanced AIDS.
    Haider A; Schliep T; Zeana C
    Am J Med Sci; 2009 Nov; 338(5):418-20. PubMed ID: 19726970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
    Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R
    Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex.
    Grosset J; Ji B
    Drugs; 1997; 54 Suppl 2():23-7; discussion 28-9. PubMed ID: 9358197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.